期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Cirugia y Cirujanos LetPub Score 5.0
50 ratings
Rate
Reputation 5.9 Influence 3.7 Speed 7.0 | ||||||||||||||||
期刊簡稱 | CIR CIR | ||||||||||||||||
ISSN | 0009-7411 | ||||||||||||||||
h-index | 14 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 20.00%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | http://new.medigraphic.com/cgi-bin/publicaciones.cgi?IDREVISTA=10 | ||||||||||||||||
在線稿件提交 | |||||||||||||||||
開放訪問 | Yes | ||||||||||||||||
出版商 | Mexican Academy of Surgery | ||||||||||||||||
主題領域 | 医学 | ||||||||||||||||
出版國/地區 | MEXICO | ||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||
創刊年 | 1933 | ||||||||||||||||
每年文章數 | 123每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 99.06% | ||||||||||||||||
OA Related Info | APC: No APC waiver:No Other charges: No Keywords: medicine、health、surgery、clinical medicine Useful LinksAims & ScopeAuthor InstructionsEditorial BoardDouble anonymous peer review | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q4
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0009-7411%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Slow, 6-12 Week(s) | ||||||||||||||||
競爭力 * | 來自作者的數據: Easy | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Cirugia y Cirujanos] 的評論 | 撰寫評論 |
作者: 右手放弃左手 領域: 医学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2023-11-27 21:46:08 評論於 Are you referring to at least six months of proof or at least six months of indexing? Also, may I ask if there is a publication fee for this journal? Thank you(0) 讚! | 右手放弃左手 |
作者: 又又的主人家 領域: 医学 審稿時間: 4.0 month(s) 結果: 修改後接受 撰寫評論 |
2023-11-23 21:07:37 評論於 At least six months(0) 讚! | 又又的主人家 |
作者: 迷你宝 領域: 医学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2023-11-23 20:44:13 評論於 How long does it take for the journal to be proofed after acceptance, and how long does it take to be available online for search?(0) 讚! | 迷你宝 |
作者: 又又的主人家 領域: 医学 審稿時間: 4.0 month(s) 結果: 修改後接受 撰寫評論 |
2022-10-27 16:43:48 評論於 The department received two papers, one of which was directly accepted and the other accepted after revision. The speed of review was acceptable, but the evaluation score was low, indicating that the requirement for article quality was not high.(0) 讚! | 又又的主人家 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 19:36:08 評論於 It is still necessary for us to clearly explain the limitations of the research in the paper and to explain how these limitations affect the conclusions of the paper, so that reviewers and other readers can understand that we have fully considered the limitations of the study. Discussing the limitations of the study in the discussion section generally adds credibility to the article. Thinking about how to overcome these limitations in future research can have a positive effect(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 15:13:46 評論於 We suggest dividing the discussion of research limitations into three parts: (1) identifying research limitations; (2) explaining research limitations in detail; and (3) proposing future research directions or improvement measures. Discussing research limitations in this order can help you clearly present the shortcomings of the research without compromising its quality and validity(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 上清雨真 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 21:13:20 評論於 How to write about limitations in a discussion?(0) 讚! | 上清雨真 |
作者: 修然小公主 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 17:54:26 評論於 Do we need to mention the limitations of the article in the discussion?(0) 讚! | 修然小公主 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us